Association of Serum Level of 25 Hydroxy-Vitamin D with Prognostic Factors for Breast Cancer |
Kermani, Iraj Asvadi
(Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital)
Kojidi, Habibeh Taghavi (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Gharamaleki, Jalil Vaez (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Sanaat, Zohreh (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Ziaei, Jamal Eivazi (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Esfahani, Ali (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Seifi, Sharareh (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Ghojazadeh, Morteza (Physiology Department, Tabriz Faculty of Medicine, Tabriz University of Medical Sciences) Dolatkhah, Roya (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Kermani, Atabak Asvadi (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) Rad, Elnaz Ghaemi (Hematology and Oncology Research Center, Shahid Ghazi Tabatabai Hospital) |
1 | Abbas S , Linseisen J , Slanger T, et al (2008). Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large caese-control study. Carcinogenesis, 29, 93-9. |
2 | Abbas S, Chang-Claude J, Linseisen J (2009). Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer, 124, 250-5. DOI ScienceOn |
3 | Alagol F, Shihadeh Y, Boztepe H (2000). Sunlight exposure and vitamin D in Turkish women. J Endocrinol Invest, 23, 173-7. DOI |
4 | Azizi F, Rais-Zadeh F, Mir Said Ghazi A (2000). Vitamin D deficiency in a group of Tehran Population. Research In Medicine, 4, 291-303. |
5 | Colton KW, James SY, Pirianov G (1999). Novel vitamin D analogues as anti-proliferative agents in cancer: cellular and molecular mechanisms of action. Curr Top Steroid Res, 2, 141-56. |
6 | Cui Y, Rohan TE (2006). Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev, 15, 1427-37. DOI ScienceOn |
7 | Dawodu A, Agarwal M, Hossain M (2003). Hypervitaminosis D and vitamin D deficiency in exclusively brest feeding infants and their mother in summer :a justification for vitamin D supplementation of brest-feeding infants. J Pediatr, 142, 169-73. DOI ScienceOn |
8 | DeVita VT , Lawrence TS, Rosenberg SA, et al(2008). DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 8th ed. Lippincott Williams & Wilkins, USA, 1606-54. |
9 | Eisman JA, Barkla DH (1987). Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res, 47, 21-5. |
10 | Frazier AL, Ryan CT, Rockett H (2003). Adolescent diet and risk of breast cancer. Breast Cancer Res, 5, R59-64. DOI |
11 | Freedman OC, Goodwin PJ (2009). The Role of Vitamin D in Breast Cancer Recurrence. Am Soc Clin Oncolo, 1, 79-83. |
12 | Garland CF, Garland FC (1980). Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol, 9, 227-31. DOI |
13 | Garland CF, Garland FC, Gorham ED (1990). Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med, 19, 614-22. DOI ScienceOn |
14 | Gissel T, Rejnmark L, Mosekilde L, Vestergaard P (2008). Intake of vitamin D and risk of breast cancer-A meta-analysis. J Steroid Biochemistry Molecular Biology, 111, 195-9. DOI ScienceOn |
15 | Goodwin PJ, Ennis M, Pritchard KI, et al (2009). Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol, 27, 3757-63. DOI ScienceOn |
16 | Goodwin PJ (2009). Vitamin D in Breast Cancer--the debate continues: An Expert Interview. Medscape, 12, 1-6. |
17 | Gorham ED, Garland FC, Garland CF (1990). Sunlight and breast cancer incidence in the USSR. Int J Epidemiol, 19, 820-4. DOI |
18 | Haq M, Kremer R, Goltzman D, et al (1993). A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J Clin Invest, 91, 2416-22. DOI ScienceOn |
19 | Hashemipour S, Larijani B, Adibi H, et al (2004). Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health, 4, 38. DOI |
20 | John EM, Schwartz GG, Dreon DM, et al (1999). Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev, 8, 399-406. |
21 | John EM, Schwartz GG, Dreon DM (1999). Vitamin D and breast cancer risk: the NHANES I Epidemiologic Follow-up Study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev, 8, 399-406. |
22 | Larsson SC, Bergkvist L, Wolk A (2009). Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women. Am J Clin Nutr, 89, 277-82. DOI |
23 | Levi F, Pasche C, Lucchini F, et al (2001). Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer, 91, 260-3. DOI ScienceOn |
24 | Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pacific Family Medicine, 7, 1-7. DOI ScienceOn |
25 | Lin J, Manson JE, Lee IM, et al (2007). Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med, 167, 1050-9. DOI ScienceOn |
26 | Mantell DJ, Owens PE, Bundred NJ (2000). 1a,25-Dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res, 87, 214-20. DOI ScienceOn |
27 | Mathiasen IS, Lademann U, Jaattela M (1999). Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res, 59, 4848-56. |
28 | Nakagawa K, Kawaura A, Kato S, et al(2005). 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis, 26, 429-40. |
29 | Palmieri C, MacGregor T, Girgis S, et al (2006). Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol, 59, 1334-6. DOI ScienceOn |
30 | Robien K, Cutler GJ, Lazovich D (2007). Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control, 18, 775-82. DOI ScienceOn |
31 | Rossi M, McLaughlin JK, Lagiou P, et al (2009). Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol, 20, 374-8. |
32 | Shin MH, Holmes MD, Hankinson SE, et al (2002). Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst, 94, 1301-11. DOI |
33 | Simard A, Vobecky J, Vobecky JS (1991). Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can J Public Health, 82, 300-3. |
34 | Van den Bemd GJCM, Pols HAP, van Leeuwen JPTM. (2000). Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs. Curr Pharm Des, 6, 717-32. DOI ScienceOn |
35 | Van Weelden K, Flanagan L, Binderup L (1998). Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog EB1089. Endocrinology, 139, 2102-10. DOI ScienceOn |
36 | Witte JS, Ursin G, Siemiatycki J (1997). Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res Treat, 42, 243-51. DOI ScienceOn |